Day One Biopharmaceuticals (DAWN) Q1 2026 Earnings

24FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-0.44
-0.34
-0.25
-0.15

Details

Expected EPS
-0.14887
Actual EPS
-0.21
Surprise EPS
-0.06
Surprise Percent
+41.06%

Description

Day One Biopharmaceuticals (DAWN) has reported earnings of -0.21 per share for Q1 2026.

0 Comments

Share your thoughts